Prasad Gade, MD
Vascular Surgery · Evansville, INNPI 1124027008
Payments from drug & device makers
What this record shows
It is spread thinly across 47 manufacturers, the largest accounting for just 20.8%. Reporting peaked in 2024 at $2,196 and has fallen 76.2% since, to $523 in 2025.
Across 152 payments — averaging $58.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$2K
- Medtronic$2K
- Silk Road Medical, Inc.$1K
- Zimmer Biomet$595
- Johnson & Johnson$540
- Livanova USA, Inc.$269
- plus $3K from 41 others
What the payments were for
- Travel & lodging$4,00045%
- Food & beverage$4,89055%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$1,713
- ENROUTE Transcarotid Neuroprotection System$1,332
- ENROUTE Transcarotid Stent System$1,189
- ENHANCE Transcarotid Peripheral Access Kit$1,189
- ENROUTE 0.014 Guidewire$1,189
- PIVOX Oblique Lateral Spinal System$1,069
- AdvantageRib$478
- ENROUTE Transcarotid Stent$143
- Kerendia$128
- CAMZYOS$128
- Omnia$101
How this compares
$8,890 in reported general payments places this provider in the 65th percentile of 71 vascular surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $9,287 |
| Cilostazol | 123 | $3,099 |
| ClopidogrelClopidogrel Bisulfate | 167 | $1,122 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 61 | $250 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Evansville
- Angela MartinEvansville$54K
- Matthew LangenbergEvansville$36K
- Chandrasekhar CherukupalliEvansville$19K
- Donald PattersonEvansville$11K
- Michael ShaoFort Wayne$155K
- Sajjad HussainIndianapolis$109K
- Ricardo VasquezBloomington$82K
- Andres FajardoIndianapolis$58K
- Luis GomezMishawaka$52K
- Brandon DowningIndianapolis$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.